Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000258715

Medchemexpress LLC N-cyclobutyl-N-(4-ethylphenyl)-4-hydroxy-2-(oxan-4-yl)-3,4-dihydro-2H-chromene-6-sulfonamide | 2230779-18-5 | 99.3% | C26H33NO5S | 10MG
SDP

Catalog No. 5000258715
Encompass_Preferred

RORγt inverse agonist 23 is a potent, selective, orally available small-molecule inverse agonist of the retinoic acid receptor-related orphan receptor γt (RORγt), intended for preclinical research into RORγt-mediated immune signaling. The compound is provided as a characterized solid with associated structural identifiers to support reproducible research.

  • Potent, selective inverse agonist of RORγt.
  • Orally available small-molecule suitable for in vivo and in vitro studies.
  • High purity (~99.3%).
  • Multiple pack sizes including mg-scale and DMSO solutions.
  • Supplied with structural identifiers for unambiguous identification.

Catalog No. 50-002-58715 Supplier Medchemexpress LLC Supplier No. HY13984710MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

RORγt inverse agonist 23 is a potent, selective, orally available small-molecule inverse agonist of the retinoic acid receptor-related orphan receptor γt (RORγt), intended for preclinical research into RORγt-mediated immune signaling. The compound is provided as a characterized solid with associated structural identifiers to support reproducible research.

  • Potent, selective inverse agonist of RORγt.
  • Orally available small-molecule suitable for in vivo and in vitro studies.
  • High purity (~99.3%).
  • Multiple pack sizes including mg-scale and DMSO solutions.
  • Supplied with structural identifiers for unambiguous identification.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.